Galmed Pharmaceuticals LTD F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
NASDAQ
Galmed Pharmaceuticals Ltd. filed an F-1 to register up to 7.5 million ordinary shares for resale by YA II PN, LTD., aiming to raise up to $20 million for pipeline development and general corporate purposes.
NASDAQ
Galmed Pharmaceuticals plans to raise up to $20 million through a share resale program with YA II PN, LTD., aiming to fund pipeline development and new ventures.
NASDAQ
F-1: Galmed Pharmaceuticals Seeks to Raise Up to $10 Million Through Standby Equity Purchase Agreement
Galmed Pharmaceuticals enters into a Standby Equity Purchase Agreement with YA II PN, LTD. to potentially raise up to $10 million through the sale of ordinary shares.